Degradation of Cdc25A by β-TrCP during S phase and in response to DNA damage
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
The Cdc25A phosphatase is essential for cell-cycle progression because of its function in dephosphorylating cyclin-dependent kinases. In response to DNA damage or stalled replication, the ATM and ATR protein kinases activate the checkpoint kinases Chk1 and Chk2, which leads to hyperphosphorylation of Cdc25A. These events stimulate the ubiquitin-mediated proteolysis of Cdc25A and contribute to delaying cell-cycle progression, thereby preventing genomic instability. Here we report that beta-TrCP is the F-box protein that targets phosphorylated Cdc25A for degradation by the Skp1/Cul1/F-box protein complex. Downregulation of beta-TrCP1 and beta-TrCP2 expression by short interfering RNAs causes an accumulation of Cdc25A in cells progressing through S phase and prevents the degradation of Cdc25A induced by ionizing radiation, indicating that beta-TrCP may function in the intra-S-phase checkpoint. Consistent with this hypothesis, suppression of beta-TrCP expression results in radioresistant DNA synthesis in response to DNA damage--a phenotype indicative of a defect in the intra-S-phase checkpoint that is associated with an inability to regulate Cdc25A properly. Our results show that beta-TrCP has a crucial role in mediating the response to DNA damage through Cdc25A degradation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The intermediate component of this pathway is β-TrcP (an adaptor protein) that links both WEE1 [346] and claspin [347–349] with the SCF ubiquitin ligase complex and this SCFβTrcP acts as trigger of checkpoint initiation where recognition of phosphodegron β-TrcP is exposed after Chk1 mediated Phosphorylation of Cdc25A [350], as well as checkpoint recovery which is linked with Plk1 mediated Phospho”
From Molecular Mechanisms of Ultraviolet Radiation‐Induced DNA Damage and Repair (2010) · cites this paper as [350]
Citations
Cites
Control of β-Catenin Phosphorylation/Degradation by a Dual-Kinase Mechanism
Liu, C., Li, Y., Semenov, M., Han, C., Baeg, G.-H., Tan, Y., Zhang, Z., Lin, X., & He, X. (2002) · Cell · doi:10.1016/s0092-8674(02)00685-2 · Cited by 2,069
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
Carrano, A. C., Eytan, E., Hershko, A., & Pagano, M. (1999) · Nature Cell Biology · doi:10.1038/12013 · Cited by 1,543 · cited 1×
“In vitro ubiquitination assay Ubiquitin ligation was determined essentially as describe”
Self-citationThe ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis
Falck, J., Mailand, N., Syljuåsen, R. G., Bartek, J., & Lukas, J. (2001) · Nature · doi:10.1038/35071124 · Cited by 1,085
Winston, J. T., Strack, P., Beer-Romero, P., Chu, C. Y., Elledge, S. J., & Harper, J. W. (1999) · Genes & Development · doi:10.1101/gad.13.3.270 · Cited by 954
Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni Syndrome
Bell, D. W., Varley, J. M., Szydlo, T. E., Kang, D. H., Wahrer, D. C. R., Shannon, K. E., Lubratovich, M., Verselis, S. J., Isselbacher, K. J., Fraumeni, J. F., et al. (1999) · Science · doi:10.1126/science.286.5449.2528 · Cited by 904
Radiosensitivity in ataxia-telangiectasia: a new explanation.
Painter, R. B., & Young, B. R. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7315 · Cited by 789 · cited 1×
“Radioresistant DNA synthesis (RDS), a phenotype indicative of a defective intra-S-phase checkpoint, occurs in cells deficient for ATM and Chk2, two upstream negative effectors of Cdc25A abundanc”
Rapid Destruction of Human Cdc25A in Response to DNA Damage
Mailand, N., Falck, J., Lukas, C., Syljuåsen, R. G., Welcker, M., Bartek, J., & Lukas, J. (2000) · Science · doi:10.1126/science.288.5470.1425 · Cited by 787
Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication
Nash, P., Tang, X., Orlicky, S., Chen, Q., Gertler, F. B., Mendenhall, M. D., Sicheri, F., Pawson, T., & Tyers, M. (2001) · Nature · doi:10.1038/35107009 · Cited by 759 · cited 1×
“23 ), multiple phosphorylation events on the target protein enhance its interaction with the F-box protein and stimulate its polyubiquitinatio”
Kipreos, E., & Pagano, M. (2000) · Genome Biology · doi:10.1186/gb-2000-1-5-reviews3002 · Cited by 738 · cited 1×
“To achieve this, we screened several human F-box protein”
Self-citationIdentification of the receptor component of the IκBα–ubiquitin ligase
Yaron, A., Hatzubai, A., Davis, M., Lavon, I., Amit, S., Manning, A. M., Andersen, J. S., Mann, M., Mercurio, F., & Ben-Neriah, Y. (1998) · Nature · doi:10.1038/25159 · Cited by 654
Cited by
Items 201–300 of 453
Critical role for IL-1β in DNA damage-induced mucositis
Kanarek, N., Grivennikov, S. I., Leshets, M., Lasry, A., Alkalay, I., Horwitz, E. P., Shaul, Y. D., Stachler, M. D., Voronov, E., Apte, R. N., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322691111 · Cited by 53
Self-citationPathways for Genome Integrity in G2 Phase of the Cell Cycle
Kousholt, A. N., Menzel, T., & Sørensen, C. S. (2012) · Biomolecules · doi:10.3390/biom2040579 · Cited by 61
“CHK1 phosphorylation of CDC25A leads to its polyubiquitinylation and degradation by SCF-βTRCP during S and G2 phases following DNA damage [173,174].”
BackgroundBurrows, A. C., Prokop, J., & Summers, M. K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.390328 · Cited by 53
“USP37 joins Cdc25A andClaspin as an S-phase regulator that is coordinately regulated by SCF TrCP and APCCdh1 (10, 12, 18, 19, 37).”
BackgroundCyclinD-CDK4/6 complexes phosphorylate CDC25A and regulate its stability
Dozier, C., Mazzolini, L., Cénac, C., Froment, C., Burlet‐Schiltz, O., Besson, A., & Manenti, S. (2017) · Oncogene · doi:10.1038/onc.2016.506 · Cited by 48
Gil-Bernabé, A. M., Romero, F., Limón-Mortés, M. C., & Tortolero, M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01904-05 · Cited by 47
Zou, C., Butler, P. L., Coon, T. A., Smith, R. M., Hammen, G. F., Zhao, Y., Chen, B. B., & Mallampalli, R. K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.192377 · Cited by 45
Less-well known functions of cyclin/CDK complexes
Palmer, N., & Kaldis, P. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.04.003 · Cited by 51
ERK and the F-box Protein βTRCP Target STAT1 for Degradation
Soond, S. M., Townsend, P. A., Barry, S. P., Knight, R. A., Latchman, D. S., & Stephanou, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800384200 · Cited by 44
RetractedLawford‐Smith, H. (2015) · Journal of Social Ontology · doi:10.1515/jso-2015-0008 · Cited by 59
Rad9 Protects Cells from Topoisomerase Poison-induced Cell Death
Loegering, D. A., Arlander, S. J. H., Hackbarth, J. S., Vroman, B. T., Roos‐Mattjus, P., Hopkins, K. M., Lieberman, H. B., Karnitz, L. M., & Kaufmann, S. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313536200 · Cited by 49
CRL Ubiquitin Ligases and DNA Damage Response
Li, J.-M., & Jin, J. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00029 · Cited by 45
“The consequence of Cdc25A turnover is persistent Cdk phosphorylation and cell cycle arrest at S-phase upon DDR (Busino et al., 2003; Jin et al., 2003).”
BackgroundInfluentialSMG-1 suppresses CDK2 and tumor growth by regulating both the p53 and Cdc25A signaling pathways
Gubanova, E., Issaeva, N., Göktürk, C., Djureinovic, T., & Helleday, T. (2013) · Cell Cycle · doi:10.4161/cc.26660 · Cited by 47
SCFβ-TRCP promotes cell growth by targeting PR-Set7/Set8 for degradation
Wang, Z. P., Dai, X., Zhong, J., Inuzuka, H., Wan, L., Li, X., Wang, L., Ye, X., Sun, L., Gao, D., et al. (2015) · Nature Communications · doi:10.1038/ncomms10185 · Cited by 44
Helena, J., Joubert, A. M., Grobbelaar, S., Nolte, E., Nel, M., Pepper, M. S., Coetzee, M., & Mercier, A. E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041148 · Cited by 50
“Chk1 also phosphorylates and activates Wee1 kinase to inhibit the G2/M phase transition [41,42].”
BackgroundGenomic and functional characterization of StCDPK1
Gargantini, P. R., Giammaria, V., Grandellis, C., Feingold, S. E., Maldonado, S., & Ulloa, R. M. (2009) · Plant Molecular Biology · doi:10.1007/s11103-009-9462-5 · Cited by 43
“Typically; specific phosphorylation of target sequences is required for efficient F-box-mediated recruitment of target proteins to SCF E3 ubiquitin ligase complexes (Patton et al. 1998; Jackson and Eldridge 2002; Busino et al. 2003 ).”
BackgroundIsoda, M., Kanemori, Y., Nakajo, N., Uchida, S., Yamashita, K., Ueno, H., & Sagata, N. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-01-0008 · Cited by 47
“Chk1 phosphorylates and targets Cdc25A for SCF-TrCPdependent degradation both in mammalian cells and Xenopus embryos ( Busino et al., 2003; Jin et al., 2003; Kanemori et al., 2005).”
BackgroundMethodInfluentialTargeting SCF E3 Ligases for Cancer Therapies
Liu, J., Peng, Y., Zhang, J., Long, J., Liu, J., & Wei, W. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1025-0_9 · Cited by 42
Hülsmann, J., Kravić, B., Weith, M., Gstaiger, M., Aebersold, R. H., Collins, B. C., & Meyer, H. H. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra117.000471 · Cited by 46
SMC1-Mediated Intra-S-Phase Arrest Facilitates Bocavirus DNA Replication
Luo, Y., Deng, X., Cheng, F., Li, Y., & Qiu, J. (2013) · Journal of Virology · doi:10.1128/jvi.03396-12 · Cited by 41
Qin, J.-L., Qin, Q., Wei, Z., Yu, Y.-C., Meng, T., Wu, C., Liang, Y., Liang, H., & Chen, Z. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.08.054 · Cited by 42
Regulation of lung cancer cell growth and invasiveness by β‐TRCP
He, N., Li, C., Zhang, X., Sheng, T., Chi, S., Chen, K., Wang, Q., Vertrees, R. A., Logroño, R., & Xie, J. (2004) · Molecular Carcinogenesis · doi:10.1002/mc.20063 · Cited by 45
Structure of the human UBR5 E3 ubiquitin ligase
Wang, F., He, Q., Zhan, W., Yu, Z., Finkin-Groner, E., Ma, X., Lin, G., & Li, H. (2023) · Structure · doi:10.1016/j.str.2023.03.010 · Cited by 39
Cyclers’ kinases in cell division: from molecules to cancer therapy
Milletti, G., Colicchia, V., & Cecconi, F. (2023) · Cell Death & Differentiation · doi:10.1038/s41418-023-01196-z · Cited by 39
Degradation of p12 Subunit by CRL4Cdt2 E3 Ligase Inhibits Fork Progression after DNA Damage
Terai, K., Shibata, E., Abbas, T., & Dutta, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.c113.505586 · Cited by 39
Titanium dioxide nanoparticles activate the ATM-Chk2 DNA damage response in human dermal fibroblasts
Prasad, R. Y., Chastain, P. D., Nikolaishvili‐Feinberg, N., Smeester, L., Kaufmann, W. K., & Fry, R. C. (2012) · Nanotoxicology · doi:10.3109/17435390.2012.710659 · Cited by 41
“ATM phosphorylates Chk2 and pChk2 proceeds to phosphorylate Cdc25A to induce ubiquitinmediated proteolysis of Cdc25A, resulting in inhibition of DNA synthesis (Busino et al. 2003).”
Liu, X., Zong, W., Li, T., Wang, Y., Xu, X., Zhou, Z., & Wang, Z. (2017) · The EMBO Journal · doi:10.15252/embj.201694443 · Cited by 39
“For the cell synchronization, we followed a previous protocol (Busino et al, 2003) with minor modifications.”
BackgroundMethodKhalafalla, F. G., & Khan, M. W. (2017) · Cancer Growth and Metastasis · doi:10.1177/1179064417709287 · Cited by 42
The ATM regulated DNA damage response pathway as a chemo- and radiosensitisation target
Alao, J. P. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440902835475 · Cited by 38
DNA Damage Regulates Translation through β-TRCP Targeting of CReP
Loveless, T. B., Topacio, B. R., Vashisht, A. A., Galaang, S., Ulrich, K. M., Young, B. D., Wohlschlegel, J. A., & Toczyski, D. P. (2015) · PLOS Genetics · doi:10.1371/journal.pgen.1005292 · Cited by 34
Wrenches in the works: drug discovery targeting the SCF ubiquitin ligase and APC/C complexes
Cardozo, T. J., & Pagano, M. (2007) · BMC Biochemistry · doi:10.1186/1471-2091-8-s1-s9 · Cited by 39
Self-citationPhosphatase Cdc25A Negatively Regulates the Antiviral Immune Response by Inhibiting TBK1 Activity
Qi, D., Hu, L., Jiao, T., Zhang, T., Tong, X., & Ye, X. (2018) · Journal of Virology · doi:10.1128/jvi.01118-18 · Cited by 38
Weissman, A. M. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.04.011 · Cited by 39
“Two similar sites have previously been identified in Cdc25A (Busino et al., 2003; Ray et al., 2005).”
BackgroundCukras, S., Morffy, N., Ohn, T., & Kee, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101844 · Cited by 47
“To name a few mechanisms, CUL1 forms a complex with a F-box protein b-TRCP to regulate degradation of several cell cycle checkpoint and DDR proteins, including CDC25A, WEE1, CLASPIN, FANCM, and MDM2 [14–20].”
BackgroundYong-sheng, W., Feng, X., Jin, Y., Wu, Z., Hankey, W., Paisie, C. A., Li, L., Liu, F., Barsky, S. H., Zhang, W., et al. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0213 · Cited by 37
“Cdc25A is rapidly degraded in a proteasome-dependent manner in cells exposed to UV light, hydroxyurea, or ionizing radiation (12, 22, 23).”
BackgroundA genome-scale CRISPR-Cas9 screening method for protein stability reveals novel regulators of Cdc25A
Wu, Y., Zhou, L., Wang, X., Lu, J., Zhang, R., Liang, X., Wang, L., Deng, W., Zeng, Y.-X., Huang, H., et al. (2016) · Cell Discovery · doi:10.1038/celldisc.2016.14 · Cited by 35
Cova, G., Glaser, J., Schöpflin, R., Prada‐Medina, C. A., Ali, S., Franke, M., Falcone, R., Federer, M., Ponzi, E., Ficarella, R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37057-z · Cited by 35
Dissecting the role of ubiquitylation in the DNA damage response checkpoint in G2
Bassermann, F. C., & Pagano, M. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.104 · Cited by 40
Self-citationDeletion analysis of BMI1 oncoprotein identifies its negative regulatory domain
Yadav, A. K., Sahasrabuddhe, A. A., Dimri, M., Bommi, P. V., Sainger, R., & Dimri, G. P. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-158 · Cited by 38
“The SCF complex is involved in proteosome-mediated degradation of several proteins known to be involved in cell cycle and oncogenesis such as CDC25A [51-53], Gli [54,55] Mcl-1 [56], and PDCD4 [57].”
BackgroundIm, J., Keaton, M., Lee, K. Y., Kumar, P., Park, J.-H., & Dutta, A. (2014) · Genes & Development · doi:10.1101/gad.239194.114 · Cited by 37
“CRL1bTRCP is well known to target several proteins, such as CDC25A/B and Claspin, to regulate the response to DNA damage and replication stress in mammalian cells (Busino et al. 2003; Jin et al. 2003; Frescas and Pagano 2008).”
BackgroundIt takes two to tango: Ubiquitin and SUMO in the DNA damage response
Bologna, S., & Ferrari, S. M. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00106 · Cited by 39
“This, in turn, allows recruitment of the SCFβ−TrcP E3 ligase that promotes CDC25A poly-ubiquitylation (Busino et al., 2003).”
BackgroundFEM1 proteins are ancient regulators of SLBP degradation
Dankert, J. F., Pagan, J. K., Starostina, N. G., Kipreos, E. T., & Pagano, M. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1284715 · Cited by 34
Self-citationThe dual effects of Cdh1/APC in myogenesis
Li, W., Wu, G. Y., & Wan, Y. (2007) · The FASEB Journal · doi:10.1096/fj.07-8159com · Cited by 38
Zhao, T., Sun, Q., Rincon, S. V. D., Lovato, A., Marques, M., & Witcher, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092853 · Cited by 34
“Chk2 activation targets CDC25A for phosphorylation and subsequent degradation [23].”
BackgroundLiu, G., Zhang, Q., Li, X., Shi, M., Cai, J. L., Zhang, H., Li, J., Lin, G., Xie, W., Zhang, Y., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1927-0 · Cited by 34
Differential mitotic degradation of the CDC25B phosphatase variants
Kieffer, I., Lorenzo, C., Dozier, C., Schmitt, E., & Ducommun, B. (2007) · Oncogene · doi:10.1038/sj.onc.1210596 · Cited by 37
“The F-box protein that targets phosphorylated CDC25A for degradation by the SCF protein complex on DNA damage and during interphase was subsequently reported to be the b-TrCP protein (Busino et al., 2003; Jin et al., 2003).”
BackgroundCiclopirox inhibits cancer cell proliferation by suppression of Cdc25A
Shen, T., Shang, C., Zhou, H., Luo, Y., Barzegar, M., Odaka, Y., Wu, Y., & Huang, S. (2017) · Genes & Cancer · doi:10.18632/genesandcancer.135 · Cited by 32
SCF-Fbxo42 promotes synaptonemal complex assembly by downregulating PP2A-B56
Barbosa, P., Zhaunova, L., Debilio, S., Steccanella, V., Kelly, V. C., Ly, T., & Ohkura, H. (2020) · The Journal of Cell Biology · doi:10.1083/jcb.202009167 · Cited by 32
“(Busino et al., 2003; Guderian et al., 2010; Margottin-Goguet et al., 2003; Watanabe et al., 2004), although none of these substrates has been linked to the synaptonemal complex or the karyosome in any species.”
BackgroundGao, D., Inuzuka, H., Tseng, A., & Wei, W. (2009) · Cell Division · doi:10.1186/1747-1028-4-11 · Cited by 34
“The well-characterized F-box proteins Skp2, Cdc4/Fbw7, and β-Trcp1 target p27 [5], cyclin E [6,7], and Cdc25A [8,9], respectively, for ubiquitination and degradation.”
BackgroundLuo, Y., Liu, Y., Wu, L., Ma, X., Liu, Q., Huang, F., Zhang, X., Zhang, Y., Zhang, J., Luo, H., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900125 · Cited by 32
Stolfi, C., Fina, D., Caruso, R., Caprioli, F., Fantini, M. C., Rizzo, A., Sarra, M., Pallone, F., & Monteleone, G. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn122 · Cited by 35
Recombination‐activating gene proteins: more regulation, please
Sadofsky, M. J. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00164.x · Cited by 31
Hebeisen, M., & Roy, R. (2008) · Development · doi:10.1242/dev.014969 · Cited by 33
“The ubiquitinmediated degradation of the different Cdc25 paralogues is triggered by the APC/CCdh1 (activator=Cdc20 homologue) at the end of mitosis through recognition of a KEN box, while during S and G2 phase the abundance of Cdc25A is regulated by the SCF TrCP (Fbox= -transducin repeat-containing protein) E3 ubiquit…”
BackgroundInfluentialBecker, D., Reydelet, Y., Lopez, J. A., Jackson, C. E., Colbourne, J. K., Hawat, S., Hippler, M., Zeis, B., & Paul, R. J. (2018) · BMC Genomics · doi:10.1186/s12864-018-4742-6 · Cited by 34
“roles in regulating cell cycle checkpoints (for instance, in response to DNA damage) and promoting protein translation and cell growth [26, 27].”
BackgroundWang, M., Zhou, Z., Khan, M. J., Gao, J., & Loor, J. J. (2015) · Journal of Dairy Science · doi:10.3168/jds.2015-9430 · Cited by 35
“In that context, and even though only a single-time-of-day sample was evaluated, the upregulation of FBXW11 (also known as βTrCP) expression in response to genotoxic stress contributes to decreasing the activity of CDK1 by mediating the degradation of CDC25A in coordination with Chk1 (Busino et al., 2003), thereby pre…”
BackgroundMethodBassermann, F. C., von Klitzing, C., Illert, A. L., Münch, S., Morris, S. W., Pagano, M., Peschel, C., & Duyster, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610819200 · Cited by 31
Self-citationThe Adaptive Mechanisms and Checkpoint Responses to a Stressed DNA Replication Fork
Saldanha, J., Rageul, J., Patel, J. A., & Kim, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310488 · Cited by 30
Activation of DNA damage response signaling in mammalian cells by ionizing radiation
Ghosh, S., & Ghosh, A. (2021) · Free Radical Research · doi:10.1080/10715762.2021.1876853 · Cited by 33
Localization and function of the Ska complex during mouse oocyte meiotic maturation
Zhang, Q.-H., Qi, S., Wang, Z.-B., Yang, C., Wei, Y., Chen, L., Ouyang, Y., Hou, Y., Schatten, H., & Sun, Q. (2012) · Cell Cycle · doi:10.4161/cc.11.5.19384 · Cited by 30
UV-induced degradation of securin is mediated by SKP1-CUL1-βTrCP E3 ubiquitin ligase
Limón‐Mortés, M. C., Mora‐Santos, M., Espina, Á. G., Pintor‐Toro, J. A., López-Román, A., Tortolero, M., & Romero, F. (2008) · Journal of Cell Science · doi:10.1242/jcs.020552 · Cited by 36
“…CDC25A behaves similarly to securin, which is degraded at the end of mitosis by the proteasome via APC/C (Donzelli et al., 2002), whereas the SCFβTrCP complex is responsible for its degradation during S and G2 phases and in response to DNA damage (Busino et al., 2003; Falck et al., 2001).”
BackgroundThe role of the ubiquitin proteasome system in cerebellar development and medulloblastoma
Vriend, J. P., Ghavami, S., & Marzban, H. (2015) · Molecular Brain · doi:10.1186/s13041-015-0155-5 · Cited by 31
“Emi1 Cell cycle regulator kinase [167]”
Jiang, Z., Peng, T., Qian, H., Lu, C., Qiu, F. X., & Zhang, S. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0878-y · Cited by 29
Yang, L. F., Wang, N., Tang, Y., Cao, X., & Wan, M. (2006) · Human Mutation · doi:10.1002/humu.20387 · Cited by 30
“…p100 nuclear factor (NF)-kB B2 [Fong and Sun, 2002], NF-kB p105 [Lang et al., 2003], Dlg [Mantovani and Human Mutation DOI 10.1002/humu Banks, 2003], IFNAR1 Cdc25A [Busino et al., 2003], Wee1 [Watanabe et al., 2004], prolactin receptor [Li et al., 2004], and Snail [Zhou et al., 2004] proteins.”
InfluentialMyer, D. L., Robbins, S. B., Yin, M., Boivin, G. P., Liu, Y., Greis, K. D., Bahassi, E. M., & Stambrook, P. J. (2011) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2011.02.006 · Cited by 29
Agner, J., Falck, J., Lukas, J., & Bártek, J. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.08.035 · Cited by 30
Ubiquitin in Cell-Cycle Regulation and Dysregulation in Cancer
Borg, N. A., & Dixit, V. M. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-040716-075607 · Cited by 33
“…MDM2 (Inuzuka et al. 2010, Wang et al. 2012); the positive cell-cycle regulators Claspin (Mailand et al. 2006, Peschiaroli et al. 2006) and Cdc25A (Busino et al. 2003, Jin et al. 2003, Kanemori et al. 2005); and the negative cell-cycle regulators Emi1 and Wee1 (Margottin-Goguet et al. 2003,…”
BackgroundHPV-mediated regulation of SMAD4 modulates the DNA damage response in head and neck cancer
Citro, S., Miccolo, C., Medda, A., Ghiani, L., Tagliabue, M., Ansarin, M., & Chiocca, S. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02258-9 · Cited by 27
“HNC cell lines were transfected with Lipofectamine 2000 (Thermo Fisher Scientific), following manufacturers’ instruction for both siRNA oligos: siLuciferase (siLUC), E6/E7 siRNAs [21], SMAD4 (5′-GGU GAU GUU UGG GUC AGG UGC CUU ATT-3′), ΔNp63α (5′-ACA AUG CCC AGA CUC AAU UdTT-3′) and βTRCP1 (5′-GAU AAU ACC AGA GAA GAA…”
MethodSabir, S. R., Sahota, N., Jones, G. D. D., & Fry, A. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140975 · Cited by 30
“This, in turn, leads to ubiquitin-mediated degradation of Cdc25A and cell cycle arrest [11–13].”
BackgroundLozada, E., Andrysík, Z., Yin, M., Redilla, N., Rice, K., & Stambrook, P. J. (2016) · Oncotarget · doi:10.18632/oncotarget.7966 · Cited by 29
“com/oncotarget is refractory to DNA damage‐mediated degradation (Supplementary Figure S6B, see lanes 5 and 6, used as control) [39, 44], to ask whether depletion of ARD1, hence less acetylation, will allow some mutant Cdc25A degradation after etoposide administration.”
BackgroundD’Annibale, S., Kim, J., Magliozzi, R., Low, T. Y., Mohammed, S., Heck, A. J. R., & Guardavaccaro, D. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.549535 · Cited by 30
“To test whether the degradation of TFAP4 is mediated by TrCP, we silenced the expression of both TrCP1 and TrCP2 by RNAi (18, 25) in HeLa cells.”
BackgroundSelf-citationStructure and biological properties of five Pt(II) complexes as potential anticancer agents
Deng, J., Wang, J., Khan, M., Yu, P., Yang, F., & Liang, H. (2018) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2018.04.017 · Cited by 26
Tatarskiy, V. V., Simonov, Y. P., Shcherbinin, D. S., Brechalov, A. V., Georgieva, S. G., & Soshnikova, N. V. (2017) · Scientific Reports · doi:10.1038/s41598-017-05944-3 · Cited by 29
Jiang, H., Lu, Y., Liang, Y., & Liu, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027464 · Cited by 26
Madlener, S., Rosner, M., Krieger, S., Giessrigl, B., Gridling, M., Vo, T. P. N., Leisser, C., Lackner, A., Raab, I., Grusch, M., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp123 · Cited by 27
Deng, J., Yu, P., Zhang, Z., Zhang, J., Zhewen, S., Cai, M., Yuan, H., Liang, H., & Yang, F. (2019) · Metallomics · doi:10.1039/c9mt00193j · Cited by 25
Turnover of BRCA1 Involves in Radiation-Induced Apoptosis
Liu, W., Zong, W., Wu, G. Y., Fujita, T., Li, W., Wu, J. Q., & Wan, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014484 · Cited by 26
“, Bcl-2s and IAPs) have been reported to be poly- or mono-ubiquitylated resulting in their degradation or activation as signal transducer [23,24,25,26,27,28,29].”
BackgroundP53 suppresses SENP3 phosphorylation to mediate G2 checkpoint
Wang, Y., Tian, J., Huang, C., Ma, J., Hu, G., Chen, Y., Wang, T., Cai, R., Zuo, Y., Tan, H., et al. (2020) · Cell Discovery · doi:10.1038/s41421-020-0154-2 · Cited by 25
DEPTOR ubiquitination and destruction by SCFβ-TrCP
Wang, Z. P., Zhong, J., Gao, D., Inuzuka, H., Liu, P., & Wei, W. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00105.2012 · Cited by 28
SCFβ-TRCP E3 ubiquitin ligase targets the tumor suppressor ZNRF3 for ubiquitination and degradation
Ci, Y., Li, X., Chen, M., Zhong, J., North, B. J., Inuzuka, H., He, X., Li, Y., Guo, J., & Dai, X. (2018) · Protein & Cell · doi:10.1007/s13238-018-0510-2 · Cited by 24
“…oncoproteins such as β-catenin, CDC25A, FBXO5, IκB and DEP domain-containing mTOR-interacting protein (DEPTOR) (Guardavaccaro et al., 2003; Gao et al., 2011; Busino et al., 2003). β-TRCP mutations have been reported in various tumors indicating potential oncogenic functions (Fuchs et al., 2004).”
Zhang, R., Li, L., Li, H., Bai, H., Suo, Y., Cui, J., & Wang, Y. (2023) · Journal of Ginseng Research · doi:10.1016/j.jgr.2023.06.008 · Cited by 23
Yang, S. F., Nelson, C. B., Wells, J., Fernando, M., Lu, R., Allen, J. A. M., Malloy, L., Lamm, N., Murphy, V. J., Mackay, J. P., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46578-0 · Cited by 23
Ras Regulates SCFβ-TrCP Protein Activity and Specificity via Its Effector Protein NORE1A
Schmidt, M., Donninger, H., & Clark, G. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.594283 · Cited by 26
“These include a range of proteins involved in cell cycle regulation and transcriptional control, such as I B (38, 39), NF B (40), GLI2 (41, 42), REST (43, 44), ATF4 (45), CDC25A (46, 47), CDC25B (47), and Claspin (48, 49).”
BackgroundŁuczak, M. W., & Zhitkovich, A. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.05.029 · Cited by 23
“Deactivation of MYC activity by HIF-1α also results in downregulation of the cell cycle-promoting phosphatase CDC25A (Hammer et al., 2007), which did not occur in Ni-treated normal human cells further arguing against a global inhibition of MYC activity.”
InfluentialAberrant SKP1 Expression: Diverse Mechanisms Impacting Genome and Chromosome Stability
Thompson, L. L., Rutherford, K. A., Lepage, C. C., & McManus, K. J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.859582 · Cited by 23
SKP1 ‐ CUL1 ‐F‐box: Key molecular targets affecting disease progression
Zeng, X., Cao, J., Xu, J., Zhou, Z., Long, C., Zhou, Y., & Tang, J. (2025) · The FASEB Journal · doi:10.1096/fj.202402816rr · Cited by 23
Qin, Q., Meng, T., Wei, Z., Zhang, C., Liu, Y., Liang, H., & Chen, Z. (2016) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.201601030 · Cited by 22
Riemer, A., Dobrynin, G., Dressler, A., Bremer, S., Soni, A., Iliakis, G. E., & Meyer, H. H. (2014) · Cell Cycle · doi:10.4161/cc.27779 · Cited by 26
Ubiquitin-Regulated Cell Proliferation and Cancer
Pérez‐Benavente, B., Fathinajafabadi, A., & Farrás, R. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38266-7_1 · Cited by 22
The Fanconi anemia protein interaction network: Casting a wide net
Rego, M. A., Kolling, F. W., & Howlett, N. G. (2008) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.11.018 · Cited by 25
Zhang, Y.-L., Qin, Q., Cao, Q., Han, H.-H., Liu, Z.-L., Liu, Y., Liang, H., & Chen, Z. (2016) · MedChemComm · doi:10.1039/c6md00462h · Cited by 21
Role of β-TrCP ubiquitin ligase receptor in UVB mediated responses in skin
Bhatia, N., Demmer, T. A., Sharma, A. K., Elcheva, I. A., & Spiegelman, V. S. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.12.023 · Cited by 21
SCFβTrCP mediates stress-activated MAPK-induced Cdc25B degradation
Uchida, S., Watanabe, N., Kudo, Y., Yoshioka, K., Matsunaga, T., Ishizaka, Y., Nakagama, H., Poon, R. Y. C., & Yamashita, K. (2011) · Journal of Cell Science · doi:10.1242/jcs.083931 · Cited by 23
“The stability of Xenopus Cdc25A was also found to be strongly affected by negatively charged amino acids surrounding the constitutive TrCP-binding motif DDG (Kanemori et al., 2005).”
BackgroundInfluentialIntegrating S-phase checkpoint signaling with trans-lesion synthesis of bulky DNA adducts
Barkley, L. R., Ohmori, H., & Vaziri, C. (2007) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-007-0032-7 · Cited by 21
Iwashita, Y., Fukuchi, N., Waki, M., Hayashi, K., & Tahira, T. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.298521 · Cited by 23
“Our protein interaction results also showed an interaction ofMIBP1 with E3 ubiquitin ligase components, namely CUL1 and FBXW11/ -TrCP2 (56).”
BackgroundCheckpoint and Coordinated Cellular Responses to DNA Damage
Yang, X. H., & Zou, L. (2006) · Springer eBooks · doi:10.1007/b136684 · Cited by 30
Rasool, R. U., O’Connor, C. M., Das, C. K., Alhusayan, M., Verma, B. K., Islam, S., Frohner, I. E., Deng, Q., Mitchell-Velasquez, E., Sangodkar, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40760-6 · Cited by 22
Self-citationXavier, S., MacDonald, S., Roth, J., Caunt, M., Akalu, A., Morais, D., Buckley, M. T., Liebes, L., Formenti, S. C., & Brooks, P. C. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.01.010 · Cited by 23
A unique insertion in STARD9's motor domain regulates its stability
Senese, S., Cheung, K. A. K., Lo, Y., Gholkar, A. A., Xia, X., Wohlschlegel, J. A., & Torres, J. Z. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-03-0829 · Cited by 20
“…binds to STARD9-MD and is required for its degradation The binding of β-TrCP to canonical (DpSG(2X)pS) and extended phosphodegrons (DpSG(3X)pS or DpSG(4X)pS) is critical for SCFβ-TrCP substrate ubiquitination and degradation (Margottin et al., 1998; Busino et al., 2003; Lang et al., 2003).”
BackgroundQin, Q., Qin, J.-L., Meng, T., Yang, G.-A., Wei, Z., Liu, Y., Liang, H., & Chen, Z. (2016) · Scientific Reports · doi:10.1038/srep37644 · Cited by 18
SCFSKP2 regulates APC/CCDH1-mediated degradation of CTIP to adjust DNA-end resection in G2-phase
Li, F., Mladenov, E., Mortoga, S., & Iliakis, G. E. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02755-9 · Cited by 21
Phosphorylation and SCF-mediated degradation regulate CREB-H transcription of metabolic targets
Barbosa, S., Carreira, S., Bailey, D., Abaitua, F., & O’Hare, P. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-04-0247 · Cited by 19
“1 flag expression vector for the F-box factor Fbw1a/βTrCP, (Busino et al., 2003) was obtained from Michele Pagano, Dept of Pathology, NYU School of Medicine.”
Method
Metadata
- Authors
- Busino, L., Donzelli, M., Chiesa, M., Guardavaccaro, D., Ganoth, D., Valerio Dorrello, N., Hershko, A., Pagano, M., & Draetta, G. F.
- Affiliations
- European Institute of Oncology (IT)
- New York University (US)
- Technion – Israel Institute of Technology (IL)
- Corresponding author
- Donzelli, Maddalena
- Venue
- Nature
- Published
- 2003-11
- Volume
- 426
- Issue
- 6962
- Pages
- 87-91
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1969210627
- Cited by
- 447
- References
- 28
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 6 · 2023: 13 · 2022: 10 · 2021: 15 · 2020: 21 · 2019: 13 · 2018: 17 · 2017: 23 · 2016: 21 · 2015: 23 · 2014: 18 · 2013: 20 · 2012: 32
- FWCI
- 8.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- Cdc25A phosphatase, β-TrCP, F-box protein, ubiquitin-mediated proteolysis, S-phase checkpoint, DNA damage response, ionizing radiation, radioresistant DNA synthesis, ATM kinase, ATR kinase, Chk1, Chk2, cell cycle progression, genomic instability
- MeSH terms
- Amino Acid Sequence, Binding Sites, DNA Damage, HeLa Cells, Humans, Molecular Sequence Data, Phosphorylation, Protein Binding, Radiation, Ionizing, S Phase, cdc25 Phosphatases, Amino Acid Motifs, Ubiquitin, beta-Transducin Repeat-Containing Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.